13 November 2020 | 10:00 hours CET - 11:00 hours CET
Let's get more solutions to patients faster! Partnering with a Venture Capitalist (VC) may fast forward your innovation, because they could bring much more to the table than just funding.
During this session you can learn more about the instrumental role VCs can play in your start-up company’s plans, the innovation ecosystem and how collaborating with them may accelerate potential breakthrough solutions to significant healthcare challenges the world faces today. Are you ready to gain valuable insights and connect with a potential partner?
On 24 June 2020 BioGeneration Ventures announced they closed their BGV IV fund of €105 million. The investments will focus on entrepreneurial innovation in therapeutics in Europe. Join JLABS virtually on 13 November, where Edward van Wezel, Managing Partner of BioGeneration Ventures, will elaborate on the firm's aim to build new companies around either single assets or technology platforms with the goal of creating transformational new medicines.
Are you looking for exposure for your company and innovation? Following the presentation, BioGeneration Ventures will meet 1-on-1 with companies, provided that they have been accepted after applying online. If you are interested in meeting with BioGeneration Ventures, apply here by 28 October, 2020.
Source: JLABS